Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management.
Sundararajan, Srinath; Kumar, Abhijeet; Poongkunran, Mugilan; Kannan, Arun; Vogelzang, Nicholas J.
; 12(8): 1067-80, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26901457
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
VEGF inhibition and renal thrombotic microangiopathy.
Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Clinical application of therapies targeting VEGF.
Cardiovascular safety of VEGF-targeting therapies: current evidence and handling strategies.
Growth factors for angiogenesis in peripheral arterial disease.
Antineoplastic agents and thrombotic microangiopathy.
Cardiovascular side effects of small molecule therapies for cancer.
Cancer: The nuances of therapy.
Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?